PDL BioPharma (PDLI) Says Class Action Suit 'Without Merit'
Tweet Send to a Friend
PDL BioPharma (NASDAQ: PDLI) has been informed of a class action lawsuit filed against the company that alleges ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE